Fosinopril TEVA 10 mg Tabletten

Hauptinformation

  • Handelsname:
  • Fosinopril TEVA 10 mg Tabletten
  • Einheiten im Paket:
  • 20 Stück, Laufzeit: 24 Monate,28 Stück, Laufzeit: 24 Monate,30 Stück, Laufzeit: 24 Monate,50 Stück, Laufzeit: 24 Monate,84 Stück
  • Verwenden für:
  • Menschen
  • Art der Medizin:
  • allopathic Droge

Dokumenten

  • für die Allgemeinheit:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie das Informationsblatt für die Öffentlichkeit.

  • Information für medizinisches Fachpersonal:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie die Packungsbeilage für medizinisches Fachpersonal.

Lokalisierung

  • Erhältlich in:
  • Fosinopril TEVA 10 mg Tabletten
    Österreich
  • Sprache:
  • Deutsch

Therapeutische Informationen

  • Therapiebereich:
  • Fosinopril

Weitere Informationen

Status

  • Quelle:
  • AGES
  • Zulassungsnummer:
  • 1-27025
  • Letzte Änderung:
  • 07-11-2016

14-12-2018

Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food

Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food

Published on: Thu, 13 Dec 2018 The European Commission asked EFSA for a scientific evaluation on the risks to human health related to the presence of perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) in food. Regarding PFOS and PFOA occurrence, the final data set available for dietary exposure assessment contained a total of 20,019 analytical results (PFOS n = 10,191 and PFOA n = 9,828). There were large differences between upper and lower bound exposure due to analytical methods with i...

Europe - EFSA - European Food Safety Authority Publications

12-12-2018

December 10, 2018: Olympus Medical Systems Corporation, Former Senior Executive Plead Guilty to Distributing Endoscopes After Failing to File FDA-Required Adverse Event Reports of Serious Infections

December 10, 2018: Olympus Medical Systems Corporation, Former Senior Executive Plead Guilty to Distributing Endoscopes After Failing to File FDA-Required Adverse Event Reports of Serious Infections

December 10, 2018: Olympus Medical Systems Corporation, Former Senior Executive Plead Guilty to Distributing Endoscopes After Failing to File FDA-Required Adverse Event Reports of Serious Infections

FDA - U.S. Food and Drug Administration

4-12-2018

Mylan Expands Its Voluntary Nationwide Recall of Valsartan Tablets, USP, Amlodipine and Valsartan Tablets, USP, and Valsartan and Hydrochlorothiazide Tablets, USP, to all Lots Within Expiry Due to The Detection of Trace Amounts of NDEA (N-Nitrosodiethylam

Mylan Expands Its Voluntary Nationwide Recall of Valsartan Tablets, USP, Amlodipine and Valsartan Tablets, USP, and Valsartan and Hydrochlorothiazide Tablets, USP, to all Lots Within Expiry Due to The Detection of Trace Amounts of NDEA (N-Nitrosodiethylam

– Mylan N.V. (NASDAQ: MYL) today announced that its U.S. based Mylan Pharmaceuticals business is expanding its consumer-level voluntary nationwide recall to include all lots of Valsartan-containing products within expiry. The 104 additional lots include 26 lots of Amlodipine and Valsartan Tablets, USP (including the 5mg/160mg, 10mg/160mg, 5mg/320mg and 10mg/320mg strengths), 51 lots of Valsartan Tablets, USP (including 40 mg, 80 mg, 160 mg and 320 mg strengths), and 27 lots of Valsartan and Hydrochloroth...

FDA - U.S. Food and Drug Administration

4-12-2018

Arnica compositum ad us. vet., Tabletten

Arnica compositum ad us. vet., Tabletten

● Die Neuzulassung erfolgte am 04.12.2018.

Institut für Veterinärpharmakologie und toxikologie

28-11-2018

Sprout Creek Farm Recalls “Kinkead” Cheese due to Possible Health Risk

Sprout Creek Farm Recalls “Kinkead” Cheese due to Possible Health Risk

Sprout Creek Farm of Poughkeepsie, New York is recalling 4 wheels of “Kinkead” cheese made on 5-10-18, because it has the potential to be contaminated with Listeria monocytogenes. Listeria monocytogenes is an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, L...

FDA - U.S. Food and Drug Administration

27-11-2018

Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of All Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets That Are Within Expiry

Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of All Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets That Are Within Expiry

Teva Pharmaceuticals has initiated a voluntary recall in the United States, to the patient level, of all lots of Amlodipine / Valsartan combination tablets and Amlodipine / Valsartan / Hydrochlorothiazide combination tablets (see table below) due to an impurity detected above specification limits in an active pharmaceutical ingredient (API) manufactured by Mylan India. The impurity found in Mylan’s valsartan API is known as N-nitroso-diethylamine (NDEA), which has been classified as a probable human carc...

FDA - U.S. Food and Drug Administration

13-12-2018

Bisoprolol comp. AbZ Filmtabletten

Rote - Liste

13-12-2018

Efavirenz Teva 600 mg Filmtabletten

Rote - Liste

13-12-2018

Ursofalk® 500mg Filmtabletten

Rote - Liste

13-12-2018

Zolpidem-ratiopharm 5 mg Filmtabletten

Rote - Liste

13-12-2018

Lisinopril comp. AbZ Tabletten

Rote - Liste

11-12-2018

Concor 5 mg/10 mg Filmtabletten

Rote - Liste

11-12-2018

Ubretid® Tabletten 5,0 mg

Rote - Liste

11-12-2018

Quetiapin TAD® 400 mg Retardtabletten

Rote - Liste

10-12-2018

Exondys (AVI BioPharma International Ltd)

Exondys (AVI BioPharma International Ltd)

Exondys (Active substance: eteplirsen) - Centralised - Refusal of marketing authorisation - Commission Decision (2018)8620 of Mon, 10 Dec 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/4355

Europe -DG Health and Food Safety

10-12-2018

Ivabradine JensonR (JensonR+ Limited)

Ivabradine JensonR (JensonR+ Limited)

Ivabradine JensonR (Active substance: ivabradine) - Centralised - Withdrawal - Commission Decision (2018)8623 of Mon, 10 Dec 2018

Europe -DG Health and Food Safety

7-12-2018

EZETROL 10 mg Tabletten

Rote - Liste

7-12-2018

Lendormin® 0,25 mg Tabletten

Rote - Liste

7-12-2018

Diabact UBT 50 mg Tabletten

Rote - Liste

6-12-2018

Imanivec® 400 mg Filmtabletten

Rote - Liste

6-12-2018

ABILIFY® Tabletten

Rote - Liste

6-12-2018

ABILIFY® Schmelztabletten

Rote - Liste

6-12-2018

Tioblis® Filmtabletten

Rote - Liste

6-12-2018

Imanivec® 100 mg Filmtabletten

Rote - Liste

5-12-2018

Levetiracetam UCB® Filmtabletten

Rote - Liste

5-12-2018

Forxiga® 5 mg/10 mg Filmtabletten

Rote - Liste

5-12-2018

Cliovelle® 1 mg/0,5 mg Tabletten

Rote - Liste

4-12-2018

GINKGOVITAL Heumann® Filmtabletten

Rote - Liste

4-12-2018

Telzir 700 mg Filmtabletten

Rote - Liste

3-12-2018

Alunbrig® Filmtabletten

Rote - Liste

29-11-2018

Arpilif 5 mg / -15 mg Tabletten

Rote - Liste

29-11-2018

Arpilif 10 mg / -30 mg Tabletten

Rote - Liste

28-11-2018

Deferipron Lipomed 500 mg Filmtabletten

Rote - Liste

28-11-2018

Xadago 50 mg / 100 mg Filmtabletten

Rote - Liste

28-11-2018

Baraclude® 0,5 mg/1 mg Filmtabletten

Rote - Liste

27-11-2018

Propofol 1% (10 mg/1 ml) MCT Fresenius

Rote - Liste

27-11-2018

Ramipril comp. AbZ Tabletten

Rote - Liste

27-11-2018

Olmedipin Filmtabletten

Rote - Liste

27-11-2018

Paroxetin-ratiopharm 40 mg Tabletten

Rote - Liste